Suppr超能文献

双基因突变为特发性低促性腺激素性性腺功能减退的可变表型负责。

Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

作者信息

Pitteloud Nelly, Quinton Richard, Pearce Simon, Raivio Taneli, Acierno James, Dwyer Andrew, Plummer Lacey, Hughes Virginia, Seminara Stephanie, Cheng Yu-Zhu, Li Wei-Ping, Maccoll Gavin, Eliseenkova Anna V, Olsen Shaun K, Ibrahimi Omar A, Hayes Frances J, Boepple Paul, Hall Janet E, Bouloux Pierre, Mohammadi Moosa, Crowley William

机构信息

Reproductive Endocrine Unit of the Department of Medicine and Harvard Reproductive Endocrine Science Centers, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

出版信息

J Clin Invest. 2007 Feb;117(2):457-63. doi: 10.1172/JCI29884. Epub 2007 Jan 18.

Abstract

Idiopathic hypogonadotropic hypogonadism (IHH) due to defects of gonadotropin-releasing hormone (GnRH) secretion and/or action is a developmental disorder of sexual maturation. To date, several single-gene defects have been implicated in the pathogenesis of IHH. However, significant inter- and intrafamilial variability and apparent incomplete penetrance in familial cases of IHH are difficult to reconcile with the model of a single-gene defect. We therefore hypothesized that mutations at different IHH loci interact in some families to modify their phenotypes. To address this issue, we studied 2 families, one with Kallmann syndrome (IHH and anosmia) and another with normosmic IHH, in which a single-gene defect had been identified: a heterozygous FGF receptor 1 (FGFR1) mutation in pedigree 1 and a compound heterozygous gonadotropin-releasing hormone receptor (GNRHR) mutation in pedigree 2, both of which varied markedly in expressivity within and across families. Further candidate gene screening revealed a second heterozygous deletion in the nasal embryonic LHRH factor (NELF) gene in pedigree 1 and an additional heterozygous FGFR1 mutation in pedigree 2 that accounted for the considerable phenotypic variability. Therefore, 2 different gene defects can synergize to produce a more severe phenotype in IHH families than either alone. This genetic model could account for some phenotypic heterogeneity seen in GnRH deficiency.

摘要

由于促性腺激素释放激素(GnRH)分泌和/或作用缺陷导致的特发性低促性腺激素性性腺功能减退(IHH)是一种性成熟的发育障碍。迄今为止,几种单基因缺陷已被认为与IHH的发病机制有关。然而,IHH家族病例中显著的家族间和家族内变异性以及明显的不完全外显率难以与单基因缺陷模型相协调。因此,我们推测在一些家族中,不同IHH位点的突变相互作用以改变其表型。为了解决这个问题,我们研究了2个家族,一个患有卡尔曼综合征(IHH和嗅觉缺失),另一个患有嗅觉正常的IHH,在这两个家族中都已鉴定出单基因缺陷:家系1中存在杂合性成纤维细胞生长因子受体1(FGFR1)突变,家系2中存在复合杂合性促性腺激素释放激素受体(GNRHR)突变,这两种突变在家族内和家族间的表达性都有显著差异。进一步的候选基因筛查发现家系1中鼻胚胎促性腺激素释放激素因子(NELF)基因存在第二个杂合性缺失,家系2中存在另一个杂合性FGFR1突变,这些可以解释相当大的表型变异性。因此,在IHH家族中,2种不同的基因缺陷协同作用可产生比单独一种缺陷更严重的表型。这种遗传模型可以解释GnRH缺乏中所见的一些表型异质性。

相似文献

1
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
J Clin Invest. 2007 Feb;117(2):457-63. doi: 10.1172/JCI29884. Epub 2007 Jan 18.
4
Complex genetics in idiopathic hypogonadotropic hypogonadism.
Front Horm Res. 2010;39:142-153. doi: 10.1159/000312700. Epub 2010 Apr 8.
5
A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
J Clin Endocrinol Metab. 2007 Mar;92(3):1155-8. doi: 10.1210/jc.2006-1183. Epub 2007 Jan 2.
7
The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Mol Hum Reprod. 2008 Jun;14(6):367-70. doi: 10.1093/molehr/gan027. Epub 2008 May 7.
10
Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations.
J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):95-100. doi: 10.4274/jcrpe.3908. Epub 2016 Dec 23.

引用本文的文献

2
Congenital Hypogonadotropic Hypogonadism With Novel Pathogenic Variants in FGFR1 and GNRHR.
JCEM Case Rep. 2025 Jan 15;3(1):luae254. doi: 10.1210/jcemcr/luae254. eCollection 2025 Jan.
3
Novel and recurrent genetic variants associated with male and female infertility.
J Appl Genet. 2025 Jan 15. doi: 10.1007/s13353-024-00935-3.
5
CHARGE syndrome in a child with a variant and a novel pathogenic variant: A case report.
Clin Pediatr Endocrinol. 2024 Oct;33(4):214-218. doi: 10.1297/cpe.2024-0006. Epub 2024 Jul 7.
7
Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With Mutations.
J Endocr Soc. 2024 Jun 13;8(8):bvae118. doi: 10.1210/jendso/bvae118. eCollection 2024 Jul 1.
8
A Korean male with Kleefstra syndrome presented with micropenis.
Ann Pediatr Endocrinol Metab. 2023 Dec;28(4):308-311. doi: 10.6065/apem.2244174.087. Epub 2023 Dec 31.
9
Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism.
Int J Mol Sci. 2023 Nov 4;24(21):15965. doi: 10.3390/ijms242115965.
10
Effects of Prokineticins on Cerebral Cell Function and Blood-Brain Barrier Permeability.
Int J Mol Sci. 2023 Oct 21;24(20):15428. doi: 10.3390/ijms242015428.

本文引用的文献

1
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
PLoS Genet. 2006 Oct 20;2(10):e175. doi: 10.1371/journal.pgen.0020175. Epub 2006 Sep 1.
2
Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
J Clin Endocrinol Metab. 2006 Oct;91(10):4006-12. doi: 10.1210/jc.2005-2793. Epub 2006 Aug 1.
3
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Mol Cell Endocrinol. 2006 Jul 25;254-255:60-9. doi: 10.1016/j.mce.2006.04.021. Epub 2006 Jun 9.
4
Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
Mol Cell Endocrinol. 2006 Jul 25;254-255:78-83. doi: 10.1016/j.mce.2006.04.006. Epub 2006 Jun 6.
5
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6281-6. doi: 10.1073/pnas.0600962103. Epub 2006 Apr 10.
6
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
Genes Dev. 2006 Jan 15;20(2):185-98. doi: 10.1101/gad.1365406. Epub 2005 Dec 29.
8
Cellular signaling by fibroblast growth factor receptors.
Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1.
10
Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
Hum Mutat. 2005 Jan;25(1):98-9. doi: 10.1002/humu.9298.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验